Announcements Trials

Browse Landscape

Phase

Status

Recruiting 6 Completed 3 Active not recruiting 3 Terminated 2 Withdrawn 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Breast Neoplasms 111 Carcinoma, Non-Small-Cell Lung 102 Prostatic Neoplasms 66 Multiple Myeloma 64 Neoplasm Metastasis 63 Colorectal Neoplasms 63 Neoplasms 59 Lung Neoplasms 51 Leukemia, Myeloid, Acute 41 Carcinoma, Hepatocellular 41 Recurrence 40 Lymphoma 40 Leukemia, Lymphocytic, Chronic, B-Cell 36 Pancreatic Neoplasms 34 Melanoma 34 Head and Neck Neoplasms 26 Glioblastoma 26 Rectal Neoplasms 25 Ovarian Neoplasms 25 Lymphoma, Large B-Cell, Diffuse 25 Leukemia 24 Brain Neoplasms 24 Squamous Cell Carcinoma of Head and Neck 23 Hematologic Neoplasms 23 Carcinoma, Renal Cell 23 Precursor Cell Lymphoblastic Leukemia-Lymphoma 22 Myelodysplastic Syndromes 20 Colonic Neoplasms 20 Triple Negative Breast Neoplasms 19 Lymphoma, Non-Hodgkin 19

Interventions

atezolizumab 1 PROSTVAC 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Withdrawn × Prostate Adenocarcinoma × Clear all

NCT04020094 2021-09-22

AtezoVax

University of Utah

Phase 2 Withdrawn

Prostate Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡